Lev Becker is a highly accomplished individual who is involved in multiple ventures and holds a prestigious academic position. He is the Co-Founder of both Onchilles Pharma and rMark Bio, two companies that are involved in the biopharmaceutical industry. Onchilles Pharma is a startup that focuses on developing cancer therapies using a unique approach that targets tumors' Achilles heel. rMark Bio is a company that leverages machine learning and artificial intelligence to improve drug discovery and development processes. In addition to his entrepreneurial endeavors, Lev Becker is also an Associate Professor at the University of Chicago. He is part of the Department of Medicine and is involved in research related to cancer biology and immunology. He has published numerous articles in scientific journals and is highly regarded in the academic community.